Western drug makers are ramping up their outsourcing of clinical research to...[India]...[N]ongovernmental organizations have criticized drug tests as exploitative and have said that India's poor will see no benefit from them, because the new medications will be expensive and out of the reach of most of the country's people...Indian authorities have ... emphasized that research firms should comply with...[international]...guidelines...which stress the safety of participants in clinical trials... The bigger companies are already playing by the rules...The pharmaceutical companies that sponsor clinical tests, squeamish about being viewed as too profit-minded, are conducting their own external audits of the studies. [refers to AstraZeneca, Eli Lilly, GlaxoSmithKline, Novo Group, Novo Nordisk (part of Novo Group), Pfizer, Reliance, Roche, Sanofi-Aventis]